This project has been with me since day 1 in the lab - a long journey of challenges, growth & incredible teamwork 🚀 So proud of @gmaci.bsky.social team for pushing this work to the finish line! Thks to collaborators (#Barbacid & #FSanchezVega labs) and @caixaresearch.bsky.social for their support

📢 New preprint out! We are thrilled to introduce our framework to track #ongoingCIN by leveraging single-cell genomics and CIN signatures: www.biorxiv.org/content/10.1...

The paper is published in @natgenet.nature.com. First authors: @bhernando.bsky.social, @jsneaththompson.bsky.social and Laura Madrid. With collaborations from Tailor Bio and @cam.ac.uk.  Funding: @saludisciii.bsky.social @cienciagob.bsky.social  @cruk-ci.bsky.social  y @lacaixa.bsky.social

The days of one-size-fits-all chemotherapy are ending. Researchers at our Institute, @cniostopcancer.bsky.social & Tailor Bio have developed a test that predicts resistance to common chemo drugs — paving the way for personalised cancer treatment. Find out more 👉 www.cruk.cam.ac.uk/news/scienti...

📢OUT TODAY @natgenet.nature.com 📰Predicting resistance to chemotherapy using chromosomal instability signatures. By @jsneaththompson.bsky.social, @gmaci.bsky.social and colleagues. ⬇️ www.nature.com/articles/s41...

🚨Chemo treatment upgrade!🚨 Check out our approach to modernise chemotherapy treatment published today in @natgenet.nature.com. From @cniostopcancer.bsky.social #TailorBio @cruk-ci.bsky.social www.nature.com/articles/s41... More details 👇